Miguel Coego Rios
Director of Finance/CFO presso CENTOGENE N.V.
Posizioni attive di Miguel Coego Rios
Società | Posizione | Inizio | Fine |
---|---|---|---|
CENTOGENE N.V. | Director of Finance/CFO | 31/03/2022 | - |
General Counsel | 08/02/2022 | - |
Storia della carriera di Miguel Coego Rios
Precedenti posizioni note di Miguel Coego Rios
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHIRE | Corporate Officer/Principal | 01/01/2011 | 01/01/2019 |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
ORPHAZYME A/S | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Irlanda | 2 |
Danimarca | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Director of Finance/CFO | 1 |
General Counsel | 1 |
Settori
Health Technology | 4 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ORPHAZYME A/S | Health Technology |
CENTOGENE N.V. | Commercial Services |
Aziende private | 2 |
---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Miguel Coego Rios
- Esperienza